Previous Episode: #248 Perv
Next Episode: #250 For Frack's Sake

This week, we're looking at controversial topics at the intersection of healthcare and ethics. Law professor and author Timothy Caulfield returns to discuss the rise of stem cell tourism at clinics worldwide. And science writer David Dobbs joins us to explain the showdown between the U.S. Food and Drug Administration and personal genomics company 23andMe.